CPAP Machines in Kentucky

Fisher & Paykel Healthcare is a global medical device manufacturer specializing in respiratory care and humidification technologies for both hospital and homecare settings. The company has over 50 years of innovation history. They design and manufacture a comprehensive portfolio of products across adult and neonatal respiratory support, sleep apnea therapy, and high-flow oxygen delivery systems. Key product families include the F&P 950 and F&P 850 Systems (advanced humidifiers), Airvo systems (Optiflow high-flow therapy platforms), Nasal Cannula interfaces, and PAP therapy masks including the Nova Nasal and Nova Micro lines. Hospital offerings span invasive and noninvasive ventilation, neonatal respiratory care, and Optiflow nasal high-flow therapy for adult patients. Homecare solutions include PAP devices for sleep apnea, myAirvo therapy systems for humidified high-flow home respiratory care, PAP masks and accessories, and digital management tools like the myMask App. The company supports clinicians through educational resources, training, and clinical evidence. Products appear designed for critical care, acute respiratory support, and chronic respiratory disease management in both institutional and home environments.

Vivos Therapeutics manufactures FDA-cleared oral appliances for the treatment of obstructive sleep apnea (OSA) in adults and children. The company's primary product line consists of the Vivos CARE appliances (DNA, mRNA, mmRNA models), which are non-surgical, time-limited alternatives to CPAP therapy and other conventional OSA treatments. The DNA appliance is FDA 510(k) cleared (K234089) for moderate-to-severe pediatric OSA in ages 6–17 requiring orthodontic treatment. The mRNA and mmRNA appliances are FDA 510(k) cleared (K230947) for mild-to-severe OSA in adults. Unlike CPAP machines, which manage symptoms through continuous air pressure, Vivos appliances are designed to rehabilitate and restore proper airway form and function, with treatment typically lasting 9–12 months and designed to achieve lasting improvement or resolution. Clinical data reports 75,000+ patients treated and 60+ peer-reviewed studies supporting the approach. The company markets to both adult and pediatric populations through a network of certified providers and emphasizes insurance coverage via pre-authorization. Vivos serves the homecare and personal medical device market, positioning its appliance as a permanent solution alternative to lifetime nightly therapy.